Cargando…
Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599136/ https://www.ncbi.nlm.nih.gov/pubmed/37886634 http://dx.doi.org/10.3389/fsurg.2023.1307330 |
| _version_ | 1785125711070101504 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10599136 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105991362023-10-26 Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients Front Surg Surgery Frontiers Media S.A. 2023-10-11 /pmc/articles/PMC10599136/ /pubmed/37886634 http://dx.doi.org/10.3389/fsurg.2023.1307330 Text en © 2023 Frontiers Editorial Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Surgery Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients |
| title | Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients |
| title_full | Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients |
| title_fullStr | Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients |
| title_full_unstemmed | Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients |
| title_short | Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients |
| title_sort | retraction: longitude variation of the microrna-497/fgf-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in her2-positive breast cancer patients |
| topic | Surgery |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599136/ https://www.ncbi.nlm.nih.gov/pubmed/37886634 http://dx.doi.org/10.3389/fsurg.2023.1307330 |
| work_keys_str_mv | AT retractionlongitudevariationofthemicrorna497fgf23axisduringtreatmentanditslinkagewithneoadjuvantadjuvanttrastuzumabinducedcardiotoxicityinher2positivebreastcancerpatients |